EDITORIAL
The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma
Demetrios Moris, Spyridon Vernadakis, Alexandros Papalampros, Athanasios Petrou, Dimitrios Dimitroulis, Eleftherios Spartalis, Evangelos Felekouras, John J.Fung; pp 1332-1336 (Pubmed Abstr, PDF)
SPECIAL ARTICLE
Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II
George D. Geromichalos, Constantinos E. Alifieris, Elena G. Geromichalou, Dimitrios T. Trafalis; pp 1337-1358 (Pubmed Abstr, PDF)
REVIEW ARTICLES
Biological characteristics of CCN proteins in tumor development
Stephany C. Barreto, Amitabha Ray, Page AG. Edgar; pp 1359-1367 (Pubmed Abstr, PDF)
Exosomal communication in glioma – a review
Hongsheng Xu, Kezhong Zhang, Hailiang Zong, Ming Shang, Kai Li, Xiaoguang He; pp 1368-1373 (Pubmed Abstr, PDF)
Removal of B-cell epitopes for decreasing immunogenicity in recombinant immunotoxin against B-cell malignancies
Xiaobo Hu, Min Zhang, Caiping Zhang, Shiyin Long, Wuzhou Wang, Weidong Yin, Zhaohui Cao; pp 1374-1378 (Pubmed Abstr, PDF)
Docetaxel in the treatment of castrate resistant advanced prostate cancer: a paradigm in change
Mircea Dediu, Florentina Bratu, Mihaela Amarandei, Eniko Fejer; pp 1379-1382 (Pubmed Abstr, PDF)
Ginseng and cancer
Ahmet Unlu, Erdinc Nayir, Onder Kirca, Hale Ay, Mustafa Ozdogan; pp 1383-1387 (Pubmed Abstr, PDF)
ORIGINAL ARTICLES
HEPATOCELLULAR CARCINOMA
S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma
Wukui Huang, Lina You, Dengyao Liu, Shufa Yang, Mo Liu, Hailin Wang, Pingju Wang, Pahaerding Baikere, Peng Gu, Abulajiang Abulikemu, Shaoha Yuan, Xiwen Fan ; pp 1388-1393 (Pubmed Abstr, PDF)
Clinical research on ultrasonically guided intrahepatic injections of HAS in interventional treatment of liver carcinomas
Peiyuan Mu, Baowei Dong , Ping Liang , Xiaoling Yu, Li Su , Jing Zhang; pp 1394-1397 (Pubmed Abstr, PDF)
Laparoscopic liver resection for malignancy in high-risk surgical patients according to ASA classification
Georgios C. Sotiropoulos, Nikolaos Machairas, Panagiota Stratigopoulou, Ioannis D. Kostakis, Dimitrios Mantas, Gregory Kouraklis; pp 1398-1402 (Pubmed Abstr, PDF)
Extended hepatectomy using the bipolar tissue sealer: an experimental model of small-for-size syndrome in pigs
Antonios Athanasiou, Michael Kontos, Emmanouil Pikoulis, John Griniatsos, Apostolos Papalois, Eleftherios Spartalis, Demetrios Moris, Evangelos Felekouras, Theodoros Liakakos; pp 1403-1409 (Pubmed Abstr, PDF)
BREAST CANCER
The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study
Suna Cokmert, Ozgur Tanriverdi, Inanc Karapolat, Lutfiye Demir, Vedat Bayoglu, Alper Can, Murat Akyol, Yasar Yilmaz, Mustafa Oktay Tarhan; pp 1410-1418 (Pubmed Abstr, PDF)
Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor
Tarik Salman, Leyla Demir, Umut Varol, Murat Akyol, Utku Oflazoglu, Yasar Yildiz, Halil Taskaynatan, Hakan Cengiz, Guven Guvendi, Yuksel Kucukzeybek, Ahmet Alacacioglu, Oktay Tarhan; pp 1419-1424 (Pubmed Abstr, PDF)
Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients
Serkan Ilgun, Dauren Sarsenov, Zeynep Erdogan, Cetin Ordu, Filiz Celebi, Kezban Nur Pilanci, Alper Ozturk, Derya Selamoglu, Gul Alco, Fatma Aktepe, Yesim Eralp, Sitki Tuzlali, Vahit Ozmen; pp 1425-1432 (Pubmed Abstr, PDF)
ABCB1-C3435T polymorphism and breast cancer risk: a case-control study and a meta-analysis
Alireza Sharif, Davood Kheirkhah, Mohammad Reza Sharif, Mohammad Karimian, Zahra Karimian; pp 1433-1441 (Pubmed Abstr, PDF)
RENAL CELL CARCINOMA
Safety profile of temsirolimus in patients with metastatic renal cell carcinoma
Iva Levakov, Sasa Vojinov, Goran Marusic, Milan Popov, Olivera Levakov, Mladen Popov, Dimitrije Jeremic; pp 1442-1448 (Pubmed Abstr, PDF)
Partial versus radical nephrectomy for pT1a renal cancer in Serbia
Aleksandar Janicic, Uros Bumbasirevic, Tatjana Pekomezovic, Milica Cekerevac4, Miodrag Acimovic, Zoran Dzamic, Cane Tulic; pp 1449-1453 (Pubmed Abstr, PDF)
HEMATOLOGICAL MALIGNANCIES
FcγRIIa-H131R variant is associated with inferior response in diffuse large B cell lymphoma: A meta-analysis of genetic risk
Panayiotis D. Ziakas, Loukia S. Poulou, Elias Zintzaras; pp 1454-1458 (Pubmed Abstr, PDF)
Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma
Lavinika Atanaskovic, Bojana Cikota-Aleksic, Olivera Tarabar, Jovana Trimcev, Andelina Zivanovic-Ivic, Slobodan Marjanovic, Zvonko Magic; pp 1459-1465 (Pubmed Abstr, PDF)
GASTRIC CANCER
Bevacizumab followed by chemotherapy is potential therapy for gastric cancer
Yalei Lv, Lina Song, Liang Chang, Yan Liu, Xiaolin Zhang, Yudong Wang, Long Wang, Wei Liu; pp 1466-1470 (Pubmed Abstr, PDF)
Clinicopathological features and prognosis of Borrmann type IV gastric cancer
Yan-li Zhu, Li Yang, Zi-qi Sui, Liang Liu, Jing-feng Du; pp 1471-1475 (Pubmed Abstr, PDF)
Tumor deposits: Prognostic significance in gastric cancer patients
Bulent Yildiz, Durmus Etiz, Pinar Dal, Bermet Junushova, Ozgul Pasaoglu, Evrim Yilmaz, Serdar Erkasap, Murat Dincer; pp 1476-1481 (Pubmed Abstr, PDF)
GYNECOLOGICAL MALIGNANCIES
EGFR inhibition studies by hybrid scaffolds for their activity against ovarian cancer
Feng Zhang, Hongyan Zhang, Fang Wang; pp 1482-1490 (Pubmed Abstr, PDF)
Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma
Yan Zhang, Xin Qu, Peng Peng Qu; pp 1491-1495 (Pubmed Abstr, PDF)
THYROID CANCER
Analysis of malignancy predictors for oxyphile thyroid tumors
Rastko Zivic, Aleksandar Diklic, Sandra Sipetic Grujicic, Ivan Paunovic, Berislav Vekic, Radoslav Perunovic, Dragan Radovanovic, Vladan Zivaljevic; pp 1496-1500 (Pubmed Abstr, PDF)
Identification of differential pathways in papillary thyroid carcinoma utilizing pathway co-expression analysis
Wei-Hai Qiu, Gui-Yan Chen, Lu Cui, Ting-Ming Zhang, Feng Wei, Yong Yang; pp 1501-1509 (Pubmed Abstr, PDF)
GASTROINTESTINAL CANCERS
Hyperthermic intraperitoneal chemotherapy plus high-frequency diathermic therapy followed by intravenous chemotherapy versus intravenous chemotherapy alone for postoperative adjuvant treatment of gastrointestinal cancer: a comparative research study
Li-Zhen Gao, E-Mei Gao, Yun-Fei Bai, Hai-Long Su, Fan Zhang, Mei-Qing Ge, Dong-Lian Liu, Yan-Kun Huang; pp 1510-1517 (Pubmed Abstr, PDF)
BLADDER CANCER
TFPI-2 expression is decreased in bladder cancer and is related to apoptosis
Chenchen Feng, Yatfaat Ho, Chuanyu Sun, Guowei Xia, Qiang Ding, Bin Gu; pp 1518-1523 (Pubmed Abstr, PDF)
LUNG CANCER
Video-assisted thoracoscopic lobectomy mitigates adverse oncological effects of delayed adjuvant chemotherapy for non-small cell lung cancer patients
Xiaogang Jing, Ying Lin, Beifeng Zhang, Guojun Zhang; pp 1524-1529 (Pubmed Abstr, PDF)
HEAD & NECK CANCER
Cytomegalovirus induces Interleukin-6 mediated inflammatory response in salivary gland cancer
Milena Radunovic, Nada Tomanovic, Ivana Novakovic, Ivan Boricic, Sanja Milenkovic, Milovan Dimitrijevic, Sanja Radojevic-Skodric, Ljiljana Bogdanovic, Gordana Basta-Jovanovic; pp 1530-1536 (Pubmed Abstr, PDF)
SUPPORTIVE CARE
The need for support among cancer patients – a preliminary study
Malgorzata Pasek, Dariusz Bazaliski, Jolanta Sawicka; pp 1537-1545 (Pubmed Abstr, PDF)
NURSING ONCOLOGY
Efficacy of whole-course pain intervention on health-related quality of life for patients after esophagectomy
Miao Zhang, Heng Wang, Xuefeng Pan, Wenbin Wu, Qi Zhang, Yun Liu, Hui Zhang; pp 1546-1551 (Pubmed Abstr, PDF)
MISCELLANEOUS
Screening for antitumor activity of various plant extracts on HeLa and C 4-I cell lines
Gul Ozcan, Ozlem Dagdeviren Ozsoylemez, Gizem Akman, Walid Khalilia, Beliz Tezel Yetiz, Ali Karagoz, Gulay Melikoglu, Sezin Anil, Sukran Kultur, Nurhayat Sutlupinar; pp 1552-1560 (Pubmed Abstr, PDF)
LETTERS TO THE EDITOR
Mixed medullary and papillary thyroid carcinoma: A stepwise diagnosis
Despoina Myoteri, Dionysios Dellaportas, Eleni Carvounis, Agathi Kondi-Pafiti, Ioannis Vassiliou; pp 1561-1562 (Pubmed Abstr, PDF)
Less is more: salvageability as the new creed in surgery of colorectal liver metastatic disease
Demetrios Moris, Nikolaos Dimitrokallis, Dimitrios Oikonomou, Eustratia Mpaili, Evangelos Felekouras; pp 1562-1563 (Pubmed Abstr, PDF)
Cervical cancer screening problem: The social and cultural matters in Iran
Faezeh Mohammadi Bezanaj, Mahboubeh Sadeghi Evari; pp 1563-1564 (Pubmed Abstr, PDF)
Regional metastatic disease caused by malignant blue naevus
Mladen Jovanovic, Milana Obradovic-Tomasev, Zlata Janjic, Aleksandar Komarcevic; pp 1564-1565 (Pubmed Abstr, PDF)
Intrascotal metastasis of bladder transitional cell carcinoma as initial presentation of the disease
Charalampos Fragkoulis, Georgios Papadopoulos, Ioannis Gkialas, Konstantinos Ntoumas; pp 1565-1566 (Pubmed Abstr, PDF)
Chemotherapy and loss of fingerprint; problematic issue beyond the side effect
Aras Mumyakmaz, Kadri Altundag; pp 1566-1567 (Pubmed Abstr, PDF)
HISTORY OF ONCOLOGY
Racial variation and cancer: a historical approach
Marianna Karamanou, Halil Tekiner, Theodoros G. Papaioannou, Konstantinos Konstantopoulos,
George Androutsos; 1568-1570 (Pubmed Abstr, PDF)
